In the last half century, the life expectancy of beta-thalassemia patients has strikingly
increased mostly due to regular blood transfusions and chelation treatments. The improved …

Abstract Background and Objectives Transfusion‐dependent β‐thalassaemia can lead to
severe psychological issues in paediatric and adolescent patients. However, the …

Objective The role of iron chelation in causing hearing loss (HL) is still unclear. The present
study assessed the prevalence of HL among transfusion-dependent thalassemia (TDT) …

Background Brain injury in hereditary hemoglobinopathies is commonly attributed to anemia-
related relative hypoperfusion in terms of impaired oxygen blood supply. Supratentorial and …

Background Despite numerous studies, the true scenario of hearing loss in beta‐
thalassaemia remains rather nebulous. Materials and methods Pure tone audiometry …

Background Hearing impairment has frequently been described in β-thalassemia patients
with a significant impact on the patients' quality of life. Most studies provided evidence of …

Las hemopatías malignas afectan con mucha frecuencia al área otorrinolaringológica
(ORL). Esta afectación puede ser primaria y hacer sospechar una hemopatía, o aparecer …

Background: Deferasirox is an oral iron chelator widely used to treat iron overload in
patients with transfusion-dependent β-thalassemia. This study investigated the prevalence …

Le emopatie maligne coinvolgono molto frequentemente la sfera oto-rino-laringoiatrica
(ORL). Questo danno può essere preliminare e far sorgere il sospetto di emopatia oppure …

The present study compared the Auditory Brainstem Response (ABR) of children with
thalassemia major and typically developing children. A total of 16 children participated in …